Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × Neurofibromatosis 2 × CNS × Clear all

Status

No longer available 1

Sponsor Class

Study Type

Interventional 29 Observational 8 Expanded_access 1

Sponsor

Cancer Type

Conditions

Neuroblastoma 11 Glioblastoma 11 Glioma 8 Pheochromocytoma 6 Neoplasms 6 Recurrence 4 Paraganglioma 4 Melanoma 3 Stomach Neoplasms 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Oligodendroglioma 2 Neurofibroma, Plexiform 2 Neuroectodermal Tumors, Primitive 2 Medulloblastoma 2 Head and Neck Neoplasms 2 Diffuse Intrinsic Pontine Glioma 2 Breast Neoplasms 2 Brain Neoplasms 2 Astrocytoma 2 Wilms Tumor 1 Urinary Bladder Neoplasms 1 Typical Teratoid Rhabdoid Tumor 1 Thyroid Neoplasms 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Retinoblastoma 1 Prostatic Neoplasms 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02589912 2019-12-06

Compassionate Use Arm - ABI541 ABI for 10 NF2 Patients

Massachusetts Eye and Ear Infirmary

No longer available

Neurofibromatosis 2

Data powered by HemOnc (CC BY 4.0) Colophon ⚡